GENE ONLINE|News &
Opinion
Blog

Drug Manufacturing
Will Biden’s Biomanufacturing Initiative Kill Korean Partnership?
2022-10-12
WuXi Biologics Adds Microbial Fermentation to CDMO Offering in Hangzhou
2022-07-05
Astellas Ups Production of Gene Therapies With New Carolina Plant
2022-06-09
EQT and Mubadala to Acquire Envirotainer in $3 Billion Deal
2022-06-08
Lonza Signs CDMO Deal to Break Into Israeli Market
2022-05-25
WuXi Biologics Launch Its Largest GMP Drug Facility and First Automated Vial Packaging Line
2021-11-03
WuXi Biologics Acquires Bayer’s Drug Manufacturing Facility in Wuppertal
2020-12-25
LATEST
Biogen’s Tofersen May Show Clinical Benefit in ALS Patients with Rare SOD1 Mutations
2023-03-21
Comparing ESG Regulations in the U.S., the U.K., and the EU
2023-03-21
See-Mode Technologies Secures Regulatory Approvals for its AI-powered Software that Automatically Analyses and Reports Breast & Thyroid Ultrasound Scans in Australia and New Zealand
2023-03-21
OncoC4 Bags $200 Million In CTLA-4 Antibody Pact With BioNTech
2023-03-21
HHS Issues Initial Guidance on Negotiation Program as Government’s Latest Move to Reduce Drug Prices
2023-03-21
First-Ever Insect Brain Neuron Map Completed
2023-03-21
AbbVie Unveils Latest Data For Skyrizi In Difficult-To-Treat Psoriasis
2023-03-20
Scroll to Top